Rani Therapeutics Inc. (RANI)
NASDAQ: RANI
· Real-Time Price · USD
0.50
-0.01 (-2.89%)
At close: Sep 22, 2025, 3:59 PM
-2.89% (1D)
| Bid | 0.37 |
| Market Cap | 36.23M |
| Revenue (ttm) | 1.2M |
| Net Income (ttm) | -29.69M |
| EPS (ttm) | -0.9 |
| PE Ratio (ttm) | -0.55 |
| Forward PE | -1.14 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 0.63 |
| Volume | 396,945 |
| Avg. Volume (20D) | 1,839,814 |
| Open | 0.50 |
| Previous Close | 0.51 |
| Day's Range | 0.50 - 0.54 |
| 52-Week Range | 0.39 - 3.75 |
| Beta | -0.02 |
| Ex-Dividend Date | n/a |
About RANI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RANI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RANI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
Rani Therapeutics Holdings shares are trading lowe...
Unlock content with
Pro Subscription
2 months ago
RANI stock has given up its prior gain. Rani Therapeutics shares were trading higher after the company announced it has unveiled preclinical data at ENDO 2025 for the RaniPill capsule.
